Search results
Wegovy Is Available Again After Shortages, FDA Says—But Supplies Are Still Limited
Forbes· 2 days agoThe 1.7 milligram (mg) dose of Wegovy is listed as available on the FDA’s drug shortage database...
TIME100 Health: Alex Oshmyansky
Time via Yahoo Finance· 1 hour agoHow does Cost Plus Drug Co. sell a popular statin for $5 a month when it costs about $200 a month everywhere else? By simply going straight to the ...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 2 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Motley Fool via Yahoo Finance· 2 hours agoEven when they target more common conditions, some biotechs have deep lineups that allow them to...
FTC targets ‘junk patents’ on Ozempic, other top drugs
BioPharma Dive via Yahoo Finance· 1 day agoThe move broadens the antitrust regulator’s campaign against allegedly “improper or inaccurate”...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 2 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
Drugmakers Exposed to Antitrust Probes if Patent Cache Adopted
Bloomberg Law· 1 day agoA proposed patent office depository for sealed settlements could expose pharmaceutical giants to antitrust scrutiny if investigators use it to identify which companies may have coaxed biosimilar ...
Drugmakers, hospitals spar over new 340B drug discount 'dispute resolution' process
BenefitsPRO· 6 days agoThe new dispute resolution process is designed to use government officials to oversee disagreements,...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 2 days agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 2 days agoThe crackdown is the latest assault against what the agency regards as drugmakers’ patent ploys...
